Genentech’s Tiffany William Brings Agile Gaming Mindset To Pharma Marketing

Genentech growth marketing leader Tiffany William has built a reputation for applying lessons from the mobile gaming world to pharmaceutical marketing strategy.

William, based in the San Francisco Bay Area, leads growth marketing efforts at Genentech, focusing on global user acquisition and engagement across key therapeutic areas.

Her career trajectory is unusual in the pharma marketing space, having crossed over from the fast-paced and data-driven world of mobile gaming into healthcare communications.

The mobile gaming industry is well known for rapid experimentation, where teams launch, measure, and iterate on campaigns at a speed rarely seen in traditional pharmaceutical marketing environments.

William has carried that same philosophy into her work at Genentech, championing a “fail fast, learn fast” approach that encourages quicker testing and smarter decision-making based on real-world data.

This mindset represents a broader shift happening across the pharmaceutical marketing industry, as companies increasingly look outside healthcare for fresh talent and unconventional strategic thinking.

Patient engagement and digital innovation have become central battlegrounds for pharma marketers, and professionals with backgrounds in high-velocity consumer industries are increasingly valued for their technical fluency and comfort with ambiguity.

Genentech, a member of the Roche Group, is one of the world’s leading biotechnology companies, giving William a significant platform to apply and scale her cross-industry approach.

William was profiled as part of FiercePharma Marketing’s Rising Stars series, which spotlights early-career professionals making a notable impact through standout campaigns and innovative digital work.

The Rising Stars series highlights individuals from both agency and in-house marketing roles who are reshaping how the pharmaceutical industry communicates with patients, providers, and broader audiences.

William’s inclusion in the series reflects growing industry recognition that diverse professional backgrounds can bring competitive advantages to pharma marketing teams navigating an increasingly complex digital landscape.

Her work underscores how the pharmaceutical sector is evolving its approach to talent, looking beyond traditional marketing pipelines to find professionals with the skills to deliver smarter, faster, and more measurable campaigns.